Al-Sawaf, O., Herling, C. D., Holtick, U., Scheid, C., Cramer, P., Sasse, S., . . . Frenzel, L. P. (2019). Venetoclax plus rituximab or obinutuzumab after allogeneic hematopoietic stem cell transplantation in chronic lymphocytic leukemia. Haematologica.
Citação norma ChicagoAl-Sawaf, Othman, et al. "Venetoclax Plus Rituximab or Obinutuzumab After Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Lymphocytic Leukemia." Haematologica 2019.
Citação norma MLAAl-Sawaf, Othman, et al. "Venetoclax Plus Rituximab or Obinutuzumab After Allogeneic Hematopoietic Stem Cell Transplantation in Chronic Lymphocytic Leukemia." Haematologica 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.